CLINICAL_TRIALS
trial_result
· 2021-03-03
Clinical Trial Update: A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive [Phase 2]
Summary
Phase 2 trial update in recurrent or metastatic cervical cancer with PD-L1 positive tumors.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Genor Biopharma Co., Ltd. | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN